AN OVERVIEW OF ENDOMETRIAL HYPERPLASIA

Endometrial Hyperplasia is referred as the endometrial cells of uterus, which keep on growing or multiplying instead of shedding because of high levels of estrogen and low or insufficient levels of progesterone. It is a pre-malignant condition but which are not invasive in nature. EH usually occurs in women between 50 – 55 yrs. Endometrium being a hormone dependent tissue depends on estrogen and progesterone for proliferation and shedding. Endometrial thickness gradually increases day by day. EH is caused by PCOS and chronic anovulation in premenopausal women. Obesity, lynch syndrome are other causes of EH. In 1994, WHO classified this EH into four groups. In 2014, WHO revised this classification into two types, one is endometrial Hyperplasia (without atypia) and second one is atypical endometrial hyperplasia or EIN. Patient with EH experiences abnormal uterine bleeding, bleeding in between periods etc… Age, nulliparity, obesity, smoking, diabetes mellitus are the risk factors and is diagnosed by endometrial biopsy, dilation, and curettage, a transvaginal ultrasound, hysteroscopy. Management of EH is based on its types. Hyperplasia without atypia is managed by the levonorgestrel-releasing intrauterine system (LNG-IUS), oral progestogens, and surgery. Atypical EH is managed by surgery hysterectomy